Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
254,691,824
-
Total 13F shares
-
222,567,692
-
Share change
-
+367,589
-
Total reported value
-
$16,538,247,163
-
Put/Call ratio
-
138%
-
Price per share
-
$74.30
-
Number of holders
-
382
-
Value change
-
+$27,217,100
-
Number of buys
-
9
-
Number of sells
-
8
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2013
As of 31 Dec 2013,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
382 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
222,567,692 shares.
The largest 10 holders included
Capital World Investors, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, State Street Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, Ameriprise Financial Inc, Clearbridge Investments, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
382
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.